Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue 12: Medication safety during pregnancy
Submit an article Journal homepage
780
Views
9
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?

María ChaparroHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Americio 17, E 2°C, 28021 Madrid, Spain+34 913093911; +34 914022299; [email protected]
, MD PhD &
Javier P GisbertHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Americio 17, E 2°C, 28021 Madrid, Spain+34 913093911; +34 914022299; [email protected]
Pages 1749-1762 | Published online: 22 Sep 2014

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gustavo Guimarães Moreira Balbi, Vinicius Domingues, Gabriela Guimarães Moreira Balbi, Guilherme Ramires De Jesús & Roger Abramino Levy. (2019) Use of synthetic and biologic DMARDs during pregnancy. Expert Review of Clinical Immunology 15:1, pages 27-39.
Read now
Konstantinos Papamichael, Gerassimos J. Mantzaris & Laurent Peyrin-Biroulet. (2016) A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn’s disease. Expert Opinion on Drug Safety 15:4, pages 493-501.
Read now

Articles from other publishers (7)

Colm McElwain, Fergus McCarthy & Cathal McCarthy. (2021) Gestational Diabetes Mellitus and Maternal Immune Dysregulation: What We Know So Far. International Journal of Molecular Sciences 22:8, pages 4261.
Crossref
María Chaparro, María G. Donday, Francisco Abad-Santos, Francisco Javier Martín de Carpi, Miguel Ángel Maciá-Martínez, Dolores Montero, Diana Acosta, Yanire Brenes & Javier P. Gisbert. (2021) The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU. Therapeutic Advances in Gastroenterology 14.
Crossref
Javier P. Gisbert & María Chaparro. (2020) Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review. Drugs 80:11, pages 1085-1100.
Crossref
S. Smitha Prabhu & Punya Suvarna. (2019) Biological agents in pregnancy and lactation – A rational approach. Journal of Skin and Sexually Transmitted Diseases 1, pages 54-60.
Crossref
Nora Kogan, Nélida Raimondo, Simon E. Gusis, Ariel Izcovich, Jorge A. Abarca Duran, Lilia Barahona‐Torres, Orestes Blanco, Gerardo B. Quintana, María C. Briones, Carla Castro, Evelyn G. Castro Vargas, Juan Criniti, Juan C. Diez de Medina, Manuel Franco, Minerva Gómez, Patricia Levrero, Jaime E. Martínez López & Fernando Valenzuela. (2019) Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis SOLAPSO – Sociedad Latinoamericana de Psoriasis (Latin American Psoriasis Society) . International Journal of Dermatology 58:S1, pages 4-28.
Crossref
Glen Doherty, Konstantinos H Katsanos, Johan Burisch, Matthieu Allez, Konstantinos Papamichael, Andreas Stallmach, Ren Mao, Ingrid Prytz Berset, Javier P Gisbert, Shaji Sebastian, Jarosław Kierkuś, Loris Lopetuso, Edyta Szymanska & Edouard Louis. (2018) European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 12:1, pages 17-31.
Crossref
J. P. Gisbert, A. C. Marín & M. Chaparro. (2015) Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti‐ TNF therapy . Alimentary Pharmacology & Therapeutics 42:4, pages 391-405.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.